NCT02408731View on ClinicalTrials.gov

A Study to Determine the Safety, Tolerability and Pharmacokinetics of PMZ-2010 (Centhaquin) in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
Healthy
Interventions
DRUG

PMZ-2010 (Centhaquin)

As per the randomization schedule, injection of PMZ-2010 or placebo (100 ml normal saline) will be administered to each subject under supervision of investigator as an intravenous infusion over one hour. PMZ-2010 will be dissolved in normal saline (100 ml) before administration.

Trial Locations (1)

Pune 411001

Jahangir Clinical Development Centre Pvt. Ltd., Pune

Sponsors

Lead Sponsor

Pharmazz, Inc.
All Listed Sponsors
lead

Pharmazz, Inc.

INDUSTRY